Barrow Robert bought DFTX
September 2, 2026 · Form 4 insider transaction
Barrow Robert bought 40,000 shares of Definium Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$0.00
Total value
N/A
InsiderBarrow Robert
RoleOfficer, Director
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateSeptember 2, 2026
Filing dateSeptember 4, 2026
Shares owned after1,513,663
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The common shares represent the first tranche of performance share units granted effective February 3, 2026. Each performance share unit represented a contingent right to receive one common share based on, and subject to, the achievement of certain clinical and regulatory milestones set forth in the Performance Share Unit Award Agreement.; Amount includes 417 shares acquired under the Definium Therapeutics, Inc. 2024 Employee Share Purchase Plan on August 17, 2026.